Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022

SELL
$46.5 - $79.14 $176,328 - $300,098
-3,792 Reduced 39.51%
5,806 $274,000
Q2 2022

Aug 15, 2022

BUY
$63.06 - $84.75 $199,017 - $267,471
3,156 Added 48.99%
9,598 $688,000
Q1 2022

May 13, 2022

SELL
$74.15 - $99.36 $70,220 - $94,093
-947 Reduced 12.82%
6,442 $514,000
Q4 2021

Feb 11, 2022

BUY
$86.01 - $102.89 $140,970 - $168,636
1,639 Added 28.5%
7,389 $723,000
Q3 2021

Nov 12, 2021

BUY
$84.7 - $96.31 $9,062 - $10,305
107 Added 1.9%
5,750 $473,000
Q2 2021

Aug 13, 2021

BUY
$76.44 - $89.57 $11,618 - $13,614
152 Added 2.77%
5,643 $474,000
Q1 2021

May 13, 2021

SELL
$67.36 - $80.76 $13,539 - $16,232
-201 Reduced 3.53%
5,491 $391,000
Q4 2020

Feb 10, 2021

BUY
$53.08 - $69.86 $302,131 - $397,643
5,692 New
5,692 $388,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.